BCL2 and primary ovarian failure: Specifically, in the premature ovarian failure rats modeled by the chemotherapeutic drug cyclophosphamide, Bcl-2 can inhibit ovarian cell apoptosis by enhancing the resistance of cells to DNA damage factors.